Direxion Daily S&P Biotech Bear 3X ETF
LABD
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that provides leveraged inverse exposure to the daily performance of the S&P Biotechnology Select Industry Index. The fund seeks daily investment results, before fees and expenses, of 300% of the inverse (opposite) of the daily S&P Biotechnology Select Industry Index performance, utilizing swap agreements, futures contracts, options, and other financial instruments to achieve its leveraged objectives; it does not invest directly in biotech stocks. LABD targets investors seeking short-term tactical opportunities in the biotechnology sector, primarily institutional and sophisticated retail traders focused on bearish bets against biotech industry volatility. Headquartered in Wilton, Connecticut, the fund operates under Direxion Shares ETF Trust, established in 2006 as part of Direxion Investments, a provider of leveraged and inverse ETFs across various asset classes including equities, commodities, and fixed income. Geographically, it trades on U.S. exchanges with global exposure tied to the index's constituents, which include biotechnology companies listed primarily on U.S. markets. No major changes, such as partnerships, acquisitions, funding rounds, new product launches, or strategic shifts, have been reported for LABD in the last 1-2 years; the fund continues its standard daily reset mechanism without reorganization or name changes.